March 14th 2025
The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.
Pharmacopoeia Compliance: Putting It All Together; What Is on the Horizon (eBook)
March 15th 2020This final article in the series has two purposes: to summarize all the considerations that go into a company’s compendial affairs program and to look ahead at topics that will likely result in further evolution in the pharmacopoeias around the world.
A Case Study in Pharmacopoeia Compliance: Excipients and Raw Materials
March 15th 2020This case study is based on the experience of one of the authors but is applicable to all companies across the broader industry, illustrating the potentially surprising point that some compliance difficulties may be of the company’s own making.
Pharmacopoeia Compliance: Putting It All Together; What Is on the Horizon
March 15th 2020This final article in the series has two purposes: to summarize all the considerations that go into a company’s compendial affairs program and to look ahead at topics that will likely result in further evolution in the pharmacopoeias around the world.
EU Regulators are Closely Monitoring Potential Impact of COVID-19 on Supply
March 13th 2020EMA, along with its partners across the European medicines regulatory network, are keeping a close watch on the pharmaceutical supply chains in the European Union as a result of the potential impact of COVID-19.
Novartis in Process of Conducting a Comprehensive Product Review of Beovu
March 6th 2020The global safety organization of Novartis is in the process of conducting a comprehensive review of a limited number of cases where patients treated with Beovu (brolucizumab) have experienced severe vision loss, inflammation, and potential retinal vasculitis.